Ever Source Wealth Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.25 Billion
- Q1 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 97 shares of ARWR stock, worth $2,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97
Previous 129
24.81%
Holding current value
$2,480
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$392 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$317 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$219 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$168 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$106 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.71B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...